Feed Hedge Funds Ban Employees from Taking Ozempic August 28, 2026 0 Min Read Share 0 Min Read SHARE Several hedge funds are reportedly prohibiting employees from using Ozempic, a popular diabetes and weight-loss medication, citing concerns about potential side effects impacting job performance. Share This Article Facebook Twitter Copy Link Leave a comment Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Building Cardano Smart Contracts with Plutus and eUTXOExplore how to build smart contracts and decentralized applications on Cardano, leveraging… Conflux CFX Drop: Analyzing the 11% Fall, Trader Sentiment, and Liquidation TrendsExplore the recent Conflux CFX drop, its 11% price decline, and why… Ethereum Leads RWA Race: Dominating the Multi-Trillion Dollar Institutional Tokenization MarketDiscover why Ethereum leads RWA race, capturing the lion's share of institutional… Michael Saylor Celebrates SpaceX IPO: Bitcoin Holdings Expand, Signaling a New Era for Corporate TreasuriesMichael Saylor celebrates the historic SpaceX IPO, which has significantly boosted corporate… Cathie Wood’s ARK Invest buys $444.3 million in SpaceX sharesCathie Wood's ARK Invest added $444 million in SpaceX shares on its… Investors acquire 259,298 Bitcoin as price dips below $60,000Investors added nearly 260,000 BTC in 10 days as Bitcoin accumulation trend…
